Takai Hirotake, Kato Izumi, Mitsunaga Kanako, Hara Mayumi, Kodama Takahiro, Kanazawa Masaki, Terai Masaru
Department of Pediatrics, Chiba Kaihin Municipal Hospital, Chiba 261-0012, Japan.
Asia Pac Allergy. 2018 Oct 18;8(4):e37. doi: 10.5415/apallergy.2018.8.e37. eCollection 2018 Oct.
Tipepidine hibenzate (Asverin) is commonly used as an antitussive drug for acute and chronic cough in various age groups and is generally safe and well-tolerated. However, we experienced a case of tipepidine hibenzate-induced anaphylactic shock in a 1-year-old boy. After ingesting cold medication including tipepidine hibenzate, the patient presented with generalized erythema and urticaria, swollen face, coughing, wheezing and vomiting, together with hypotension and a decreased level of consciousness. To identify the culprit drug, we performed skin prick tests (SPTs) and oral drug provocation tests (DPTs). SPTs revealed a negative reaction for all drugs, but DPTs caused a positive reaction only for a full therapeutic dose of tipepidine hibenzate. Physicians need to consider tipepidine hibezate as a culprit drug when anaphylaxis occurs after taking anticough or common cold medication.
联苯哌酯(安嗽灵)通常用作各年龄段急慢性咳嗽的镇咳药,一般安全且耐受性良好。然而,我们遇到一例1岁男孩因联苯哌酯诱发过敏性休克的病例。摄入含有联苯哌酯的感冒药后,该患者出现全身红斑和荨麻疹、面部肿胀、咳嗽、喘息和呕吐,同时伴有低血压和意识水平下降。为确定罪魁祸首药物,我们进行了皮肤点刺试验(SPT)和口服药物激发试验(DPT)。SPT对所有药物均显示阴性反应,但DPT仅对全治疗剂量的联苯哌酯产生阳性反应。当服用止咳药或普通感冒药后发生过敏反应时,医生需要考虑联苯哌酯为罪魁祸首药物。